Days after the U.S. Agency for International Development gutted its funding, the Stop TB Partnership was told the termination of its USAID funding is rescinded and that it can continue doing its work. But there remain unanswered questions.
“We assume it’s for the lifesaving work for which we had a waiver, but we don't know. And we asked questions, but none of our questions were answered,” Dr. Lucica Ditiu, executive director of the Stop TB Partnership, told Devex.
The partnership was among the thousands of organizations that received a suspension order in January when the Trump administration decided to freeze U.S. foreign aid and ordered those receiving U.S. funding to stop work. That led to a pause in the partnership’s grant funding for civil society organizations, but operations continued for the Global Drug Facility, which facilitates access to tuberculosis drugs and diagnostics, given its function as a lifesaving program.
About the author
Jenny Lei Ravelo@JennyLeiRavelo
Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
